Stock Events

Stock Events

Compass Therapeutics 

$2.38
44
+$0.01+0.42% Friday 20:00
-$0.02-0.85%Friday 23:48After hours

Statistics

Day High
2.37
Day Low
2.36
52W High
6.88
52W Low
1.61
Volume
88,664
Avg. Volume
-
Mkt Cap
428.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.14
-0.12
-0.1
-0.08
Expected EPS
-0.128
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-66.49MNet Income

Analyst Ratings

15.40Average Price Target
The highest estimate is 30.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMPX. It's not an investment recommendation.
Amazon
10
AMZN
Walmart
10
WMT
Apple
9
AAPL
Microsoft
9
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals competes in the biotechnology field focusing on immunology and oncology, similar to Compass Therapeutics' focus on antibody discovery and development.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biopharmaceutical company that develops therapeutics in areas overlapping with Compass Therapeutics, including cancer and inflammatory diseases.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences operates in the discovery, development, and commercialization of innovative therapeutics in areas like oncology, closely competing with Compass Therapeutics.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, including cancer, directly competing with Compass Therapeutics.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. focuses on pharmaceutical innovations including cancer treatments and immunotherapy, areas that Compass Therapeutics is also involved in.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global biopharmaceutical company that has a broad range of drug development including oncology and immunology, competing with Compass Therapeutics.
Novartis
NVS
Mkt Cap292.35B
Novartis AG focuses on patented medicines in areas including oncology, directly competing with Compass Therapeutics in the field of innovative cancer therapies.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in pharmaceuticals and diagnostics with a strong focus on oncology and immunotherapy, making it a direct competitor to Compass Therapeutics.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca operates in several therapeutic areas including oncology, respiratory, cardiovascular, and immunotherapy, competing with Compass Therapeutics' focus areas.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment Janssen, develops treatments for a wide range of diseases including cancer, competing with Compass Therapeutics in the oncology space.

About

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Show more...
CEO
Thomas J. Schuetz
Employees
39
Country
United States
ISIN
US20454B1044

Listings

BOATS
BOATS
CMPX.BOATS
XNAS
US
CMPX

0 Comments

Share your thoughts

FAQ

What is Compass Therapeutics stock price today?▼
The current price of CMPX is $2.38 USD — it has increased by +0.42% in the past 24 hours. Watch Compass Therapeutics stock price performance more closely on the chart.
What is Compass Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Compass Therapeutics stocks are traded under the ticker CMPX.
Is Compass Therapeutics stock price growing?▼
CMPX stock has fallen by -0.83% compared to the previous week, the month change is a +19.6% rise, over the last year Compass Therapeutics has showed a -30.81% decrease.
What is Compass Therapeutics market cap?▼
Today Compass Therapeutics has the market capitalization of 428.61M
When is the next Compass Therapeutics earnings date?▼
Compass Therapeutics is going to release the next earnings report on November 11, 2026.
What were Compass Therapeutics earnings last quarter?▼
CMPX earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.11 USD resulting in a -17.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Compass Therapeutics revenue for the last year?▼
Compass Therapeutics revenue for the last year amounts to 0 USD.
What is Compass Therapeutics net income for the last year?▼
CMPX net income for the last year is -66.49M USD.
How many employees does Compass Therapeutics have?▼
As of September 06, 2026, the company has 39 employees.
In which sector is Compass Therapeutics located?▼
Compass Therapeutics operates in the Health & Wellness sector.
When did Compass Therapeutics complete a stock split?▼
Compass Therapeutics has not had any recent stock splits.
Where is Compass Therapeutics headquartered?▼
Compass Therapeutics is headquartered in BOSTON, United States.